Enlicitide Synthetic Peptide | C135PS

Enlicitide Synthetic Peptide C135PS Syd Labs | Ushelf

Enlicitide Synthetic Peptide | C135PS

$1,200.00 – $4,800.00

In stock
Catalog No.: C135PS | In Vivo Grade

$1,200.00 – $4,800.00

Enlicitide Synthetic Peptide. Enlicitide Synthetic Peptide stable cell line is available for licensing to manufacture the semaglutide biosimilar. The research grade semaglutide biosimilar is for research use only (RUO).

Clear
View cart
Catalog No. C135PS
Product Name Enlicitide Synthetic Peptide
Supplier Name Syd Labs, Inc.
Brand Name Syd Labs
Source/Host The enlicitide peptide was synthesized.
Applications ELISA, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by enlicitide.
Endotoxin < 1 EU per 1 mg of the peptide by the LAL method.
Purity >98% by HPLC
Shipping The research grade enlicitide synthetic peptide is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70°C as supplied. 1 month from date of receipt, 2 to 8°C as supplied.
Note The research grade enlicitide synthetic peptide is for research use only (RUO).
Order Offline Phone: 1-617-401-8149 Fax: 1-617-606-5022 Email: message@sydlabs.com Orleave a message with a formal purchase order (PO) Or credit card.

Description

C135PS: Enlicitide Synthetic Peptide

Background

What is research grade enlicitide decanoate synthetic peptide? Research-grade Enlicitide Decanoate Synthetic Peptide is a synthetic macrocyclic peptide inhibitor targeting proprotein convertase subtilisin/kexin type 9 (PCSK9), a key regulator of low-density lipoprotein receptor (LDLR) metabolism and cholesterol homeostasis. Enlicitide decanoate (MK-0616) is designed to inhibit the interaction between PCSK9 and LDLR, thereby preventing PCSK9-mediated LDL receptor degradation, promoting LDLR recycling, and enhancing cellular uptake of low-density lipoprotein cholesterol (LDL-C). As a novel peptide-based PCSK9 inhibitor, Enlicitide Decanoate features a highly constrained macrocyclic structure that enables high-affinity target binding and improved peptide stability compared with conventional linear peptides. Research-grade Enlicitide Decanoate Synthetic Peptide is widely used as a valuable tool for studying PCSK9 signaling, LDLR regulation, cholesterol metabolism, lipid homeostasis, cardiovascular biology, and next-generation peptide drug discovery. This product is supplied for research use only (RUO) and is not intended for human therapeutic applications.

Syd Labs also provides the following GLP-1 receptor agonist synthetic peptide:
Semaglutide Synthetic Peptide
Retatrutide Synthetic Peptide
Tirzepatide Synthetic Peptide

Enlicitide Synthetic Peptide from: Enlicitide Synthetic Peptide, Research Grade – Syd Labs